Global IPV Vaccines Market
Overview:
Two vaccines are available against Polio, Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). IPV is also known as Salk vaccine and it provides children with immunity against Poliomyelitis. This heath condition causes paralysis and eventually it can lead to death. IPV dosage is suggested for individuals undergoing cancer treatment using chemotherapy, or steroid therapy. IPV are safe to use and induce immunity against polio.
Click Here for Sample Copy (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/insight/request-sample/4965
Impact of the COVID-19 Pandemic:
Coronavirus was first reported in December 2019, in China and later on it was declared as pandemic by the WHO (World Health Organization). According to the Weekly Epidemiological Update by the WHO, revealed that till 29, November 2021 more than 260 million cases of COVID-19 were reported and 5.2 million deaths were registered.
According to an article, vaccination services at the national level have decreased by 31%.ย In the private sector, the immunization services have decreased by 46.9% during February and April 2020. India and Pakistan have huge number of missed childhood vaccinations. The vaccination program in Pakistan has been stopped due to the pandemic, depriving 40 million children from taking the polio vaccine. The pandemic also helped in boosting public awareness around vaccination programs and its health benefits.
Driver:
Active key players in the market are now focusing on launching new products and agreements with the regulatory authorities, expecting to boost the growth of the global IPV vaccines market over the forecast period. For instance, four nations from Europe have introduced IPV in their Routine Immunization Program. Turkmenistan introduced the IPV program on 2 January 2018, the Republic of Moldova adapted the program on 2 April 2018, followed by Uzbekistan on 24 April 2018, and finally Kyrgyzstan adapted the program on 2 May 2018.
๐๐ ๐๐๐๐๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ฅ๐ข๐๐ค @ https://www.coherentmarketinsights.com/insight/request-customization/4965
Furthermore, adoption of inorganic growth strategies such as collaborations, mergers, acquisitions andย ย approvals by major key players in the market in order to strengthen their position in the global market is also expected to drive growth of the global IPV vaccines market during the forecast period. For instance, in June 2018, a global pharmaceutical company, AJ Vaccines gained marketing approval from a Danish Medicines Agency (DMA) for adjuvant Inactivated Polio Vaccine (IPV) Picovax. This vaccine can be used as a primary vaccine in infants from the age of 6 weeks against poliomyelitis, and it can also be used for revaccination in children, adolescents and adults.
Key Takeaways:
- Increase in the number of launches and rise in regulatory approvals are expected to boost growth of the global IPV vaccines market during the forecast period. For instance, in October 2019, a global biopharmaceutical company, Sanofi SA launched a new digital manufacturing facility for developing next-generation biotechnological products, in Massachusetts, U.S.
- IPOL/IMOVAX vaccine brand is anticipated to witness robust growth in the global IPV vaccines market over the forecast period due to increased support from the government to increase the immunization process.
Key Players:
Major key players active in the global IPV vaccines market are Sanofi S.A, PT Bio Farma, Serum Institute of India Pvt. Ltd, AJ Vaccines, and GlaxoSmithKline Plc.
Up-To Avail 30% Discount on various license types on immediate purchase (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/promo/buynow/4965
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- IPV Vaccine Country wise Adoption Status
- IPV Vaccines Supplied by UNICEF for Gavi
- Polio Vaccination Entry and Exit Requirements
- Contribution of Regulated Markets (U.S., EU5, and Others)
- Market Trends
- Regulatory Scenario
- Pipeline Analysis
- Acquisitions
- PEST Analysis
- Public and Private Pricing โ IPV Vaccine
- Epidemiology
- Market Dynamics
- Global IPV Vaccines Market โ Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact of COVID-19 on Healthcare market
- COVID-19 Epidemiology
- Global IPV Vaccines Market, By Vaccine Brand, 2021 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 โ 2028
- Segment Trends
- Poliovac (PFS/SD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Shanipv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Poliorix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Ipol/Imovax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Polymilex
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Introduction
- Global IPV Vaccines Market, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 โ 2028
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/ipv-vaccines-market-4238
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837